WCN26-3876 CIRCULATING EXTRACELLULAR VESICLE DYSFUNCTION AND microRNA-BASED RISK PREDICTION FOR KIDNEY AND CARDIOVASCULAR OUTCOMES IN CKD PATIENTS

Read full text Summarise with VIRAT
Authors: Shunsuke Inaba, Takanori Hasegawa, Yuta Nakano, Shotaro Naito, Rena Suzukawa, Tamami Fujiki, Hiroaki Kikuchi, Yutaro Mori, Fumiaki Ando, Takayasu Mori, Koichiro Susa, Soichiro Iimori
+3 more Eisei Sohara, Shinichi Uchida, Shintaro Mandai
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Adverse organ crosstalk among the kidney, cardiovascular system, and metabolic pathways has been conceptualized as the “cardiovascular–kidney–metabolic (CKM) syndrome”. Its molecular mechanisms remain largely unknown, and validated prognostic markers are lacking. We previously identified a set of micro (mi) RNAs encapsulated in circulating small extracellular vesicles (cEVs) that are physiologically protective against vascular calcification and are depleted in blood from chronic kidney disease (CKD) model rodents.

Fields of Study & Subjects

Extracellular vesicles in disease Parathyroid Disorders and Treatments Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104451–104451
Publication date
25 March 2026
Language
EN